RECRUITING

Refractive Outcomes Utilizing Two SS-OCT Biometers for IOL Power Calculations

Talk to us

Conditions

CataractBiometryIOL CalculationsARGOSIOLM700SS OCT Biometry

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to evaluate and compare the potential refractive outcomes using the Argos 1.5 biometer in the surgical planning for cataract extraction to that obtained from IOLMaster 700. Both devices are used as standard of care in surgical planning optimization for patients undergoing cataract surgery.

Official Title

Refractive Outcomes Utilizing Two SS-OCT Biometers for IOL Power Calculations

Quick Facts

Study Start:2025-01-09
Study Completion:2025-02-22
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06801678

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 21 years or older (Adult age)
  2. * Assessed to have Cataract Grade 1 and above per LOCS III or Wisconsin Grading scale in at least one eye.
  3. * Able to comprehend and sign the informed consent form.
  4. * Potential postoperative best corrected distance visual acuity (BCDVA) of 0.3 logMAR or better and targeted post-op refraction to be emmetropia, based on the investigator expert medical opinion.
  1. * No active ocular infection or inflammation
  2. * Unable to fixate due to nystagmus or other eye movement abnormality (e.g., significant strabismus)
  3. * Contraindicated for pupil dilation (e.g., narrow angles, allergies) per medical judgement of the investigator.
  4. * Any ocular disease and/or condition that, in the investigator's clinical judgment, may put the subject at significant risk, may compromise study result or may interfere significantly with the subject's participation in the study.

Contacts and Locations

Study Contact

Lexi L Guild
CONTACT
8012635705
lguild@theeyeinstitute.com
Allison Hales
CONTACT
8012635735
ahales@theeyeinstitute.com

Principal Investigator

Zachary J Zavodni, MD
PRINCIPAL_INVESTIGATOR
The Eye institute of Utah

Study Locations (Sites)

The Eye Institute of Utah
Salt Lake City, Utah, 84107
United States

Collaborators and Investigators

Sponsor: The Eye institute of Utah

  • Zachary J Zavodni, MD, PRINCIPAL_INVESTIGATOR, The Eye institute of Utah

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-09
Study Completion Date2025-02-22

Study Record Updates

Study Start Date2025-01-09
Study Completion Date2025-02-22

Terms related to this study

Keywords Provided by Researchers

  • Biometry
  • IOL Calculations
  • ARGOS
  • IOLM700
  • SS OCT Biometry

Additional Relevant MeSH Terms

  • Cataract